Journal of Vascular Surgery
Volume 31, Issue 2 , Pages 382-390 , February 2000

The S130K fibroblast growth factor–1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue

Received 8 June 1999 ,Accepted 23 November 1999.

References 

  1. Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA. Human brain-derived acidic and basic fibroblast growth factors, amino terminal sequences and specific mitogenic activities. Biochem Biophys Res Comm. 1986;135:541–548
  2. Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J, et al.  Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci U S A. 1985;82:6409–6413
  3. Thomas KA, Rios-Candelore M, Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc Natl Acad Sci U S A. 1984;81:357–361
  4. Schreiber AB, Kenney J, Kowalski J, Thomas KA, Gimenez-Gallego G, Rios-Candelore M, et al.  A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor-II. J Cell Biol. 1985;101:1623–1626
  5. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci. 1988;13:443–447
  6. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, et al.  Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature. 1998;393:812–817
  7. Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, et al.  FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. J Surg Res. 1994;57:596–612
  8. Greisler HP, Cziperle DJ, Kim DU, Garfield JD, Petsikas D, Murchan PM, et al.  Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery. 1992;112:244–255
  9. Wong P, Hampton B, Szylobryt E, Gallagher AM, Jaye M, Burgess WH. Analysis of putative heparin-binding domains of FGF-1 using site-directed mutagenesis and peptide analogues. J Biol Chem. 1995;270:25805–25811
  10. Zarge JI, Huang P, Husak V, Kim DU, Haudenschild CC, Nord RM, et al.  Fibrin glue containing fibroblast growth factor type-1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model. J Vasc Surg. 1997;25:840–849
  11. Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by plus heparin delivered from fibrin glue suspensions. Surgery. 1995;118:280–287
  12. Shireman PK, Hampton B, Burgess WH, Greisler HP. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue. J Vasc Surg. 1999;29:852–861
  13. Hedlin U, Daum G, Clowes AW. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J Vasc Surg. 1998;27:512–520
  14. Burgess WH, Shaheen AM, Ravera M, Jaye M, Donohue PJ, Winkles JA. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J Cell Biol. 1990;111:2129–2138
  15. Burgess WH, Shaheen AM, Hampton B, Donohue PJ, Winkles JA. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J Cell Biochem. 1991;45:131–138
  16. Burgess WH, Friesel R, Winkles JA. Structure-function studies of FGF-1: dissociation and partial reconstitution of certain of its biological activities. Mol Reprod Dev. 1994;39:5660
  17. Ortega S, Schaeffer MT, Soderman D, DiSalvo J, Linemeyer DL, Gimenez-Gallego G, et al.  Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. J Biol Chem. 1991;266:5842–5846
  18. Weatherford DA, Sackman JE, Reddick TT, Freeman MB, Stevens SL, Goldman MJH. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition. Surgery. 1996;120:433–490
  19. Kang SS, Ren D, Gosselin C, Greisler HP. Smooth muscle cell inhibition with endothelial cell stimulation by growth regulators within a fibrin glue delivery vehicle. Surg Forum. 1994;45:355–358

☆ Competition of interest: nil.

☆☆ Supported by grants from the NIH (R01 HL41272) and the Department of Veterans' Affairs.

★ Reprint requests: Howard P. Greisler, MD, Loyola University Medical Center, Department of Surgery, 2160 South First Avenue, Maywood, IL 60153.

★★ 0741-5214/2000/$12.00 + 0  24/6/104567

PII: S0741-5214(00)90168-X

doi: 10.1016/S0741-5214(00)90168-X

Journal of Vascular Surgery
Volume 31, Issue 2 , Pages 382-390 , February 2000

Article Tools

* Image Usage & Resolution